Barclays initiated coverage of Cencora with a rating of Overweight and set a new price target of $242.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/3/2025 | $337.00 | Equal Weight → Overweight | Wells Fargo |
| 12/4/2024 | $280.00 | Outperform | Mizuho |
| 9/18/2024 | $275.00 → $245.00 | Buy → Neutral | BofA Securities |
| 2/26/2024 | $261.00 | Outperform | Leerink Partners |
| 1/3/2024 | $242.00 | Overweight | Barclays |
| 12/14/2023 | $213.00 | Equal Weight | Wells Fargo |
| 12/14/2021 | $162.00 → $170.00 | Buy → Neutral | Citigroup |
| 11/26/2021 | $136.00 → $170.00 | Sector Perform | RBC Capital |
4 - Cencora, Inc. (0001140859) (Issuer)
4 - Cencora, Inc. (0001140859) (Issuer)
3 - Cencora, Inc. (0001140859) (Issuer)
4 - Cencora, Inc. (0001140859) (Issuer)